AMANDA PURSER: Open Payments
NPI 1689876864 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 11 payments from 9 companies in 2025. Trend: 2023 $412 · 2024 $196 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $110 |
| Amgen Inc. | 2 | $30 |
| SANOFI PASTEUR INC. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| PFIZER INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: UBRELVY, EVENITY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, CAPVAXIVE, VOQUEZNA, PREVNAR 20, Saxenda, OFEV.
Industry payments across MS — which companies pay providers there.
